Private Advisor Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,020
| Closed | -$124K | – | 2757 |
|
|
2020
Q2 | $124K | Buy |
+1,020
| New | +$124K | ﹤0.01% | 1583 |
|
|
2019
Q4 | – | Sell |
-1,946
| Closed | -$202K | – | 1697 |
|
|
2019
Q3 | $202K | Buy |
+1,946
| New | +$202K | ﹤0.01% | 1487 |
|
|
2018
Q4 | – | Sell |
-2,879
| Closed | -$354K | – | 1498 |
|
|
2018
Q3 | $354K | Buy |
+2,879
| New | +$354K | 0.01% | 1145 |
|
|
2015
Q1 | – | Sell |
-11,238
| Closed | -$251K | – | 1039 |
|
|
2014
Q4 | $251K | Buy |
11,238
+1,038
| +10% | +$23.2K | 0.02% | 783 |
|
|
2014
Q3 | $160K | Sell |
10,200
-1,025
| -9% | -$16.1K | 0.01% | 893 |
|
|
2014
Q2 | $167K | Buy |
+11,225
| New | +$167K | 0.01% | 823 |
|